In addition, a high expression of TRPM2 was closely associated with poor prognosis in bladder, head and neck, liver, and lung cancers (adenocarcinoma) (OR = 14.260–389.563), implying that TRPM2 significantly affects cancer progression (Park et al., 2016). This evidence concerns the gene TRPM2 and adenocarcinoma.